Contents

K. Conrad, R.-L. Humbel, M. Meurer, Y. Shoenfeld, E. M. Tan (Eds.)
Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Understanding Autoimmunity


  1. Methodical aspects and diagnostic strategies

  • R. L. Humbel: New developments in autoantibody detection 

  • F. Blaes, B. Lang, D. Beeson, A. Vincent: Flow cytometry as a new method for the detection of surface-antigens / surface-binding autoantibodies

  • Th. Simon, N. Joswig, H. Mossmann, R. Kneusel, H. J. Jakobsen, B. Liedvogel, H. Haubruck: New ways of standardization: Chimeric monoclonal antibodies 

  • S. Koutouzov, J.-F. Bach, A. Jeronimo, H. Campos, J.-C. Piette, Z. Amoura: The  anti-nucleosome autoantibodies: Clinical significance and the role in the diagnosis of autoimmune diseases

  • D. Villalta, R. Tozzoli, A. Doria, A. Ghirardello, P. F. Gambari, N. Bizzaro, E. Tonutti, P. Rizzotti: Antinucleosome autoantibodies in the diagnosis of SLE: A preliminary report of a comparative evaluation of three commercial methods

  • G. Morozzi, A. Simpatico, G. Pucci, S. Cucini, F. Bellisai, O. De Pitŕ, R. Marcolongo, M. Galeazzi: Anti-nucleosome autoantibodies and systemic lupus erythematosus: Experience performed by using a commercial dot kit

  • M. Linnemann, C. Geisen, S. Menn, R. Dinser, C. Herzberg, K. Wielckens: Comparison of three different dsDNA-ELISA with special regard to their efficiency in the diagnosis of systemic lupus erythematosus

  • D. Herrmann, P. Oelzner, G. Hein, R. Fünfstück, G. Stein: Anti-C1q-autoantibodies in patients suffering from systemic lupus erythematodes

  • M. Hřier-Madsen, C. Ingwersen, J. Meyrowitsch, P. Charles, J. Forslid, A. Wiik: Software-assisted recognition of fluorescent ANA patterns: Use for teaching, learning, quality assurance and standardization

  • N. Hayashi, T. Kawamoto, M. Mukai, A. Morinobu, M. Koshiba, S. Kondo, S. Kumagai: Enzyme immunoassay by a mixture of a nuclear HEp-2 cell extract and recombinant proteins is equally or more useful than immuno-fluorescence assay for detection of antinuclear antibodies (ANA) 

  • P. M. Bayer, S. Bauerfeind, J. Bienvenu, B. Fabian, N. Fabien, P. C. Frei, B. Gilburd, K.-G. Heide, M. Hoier-Madsen, P. L. Meroni, J. C. Monier, G. Monneret, P. Panzeri, Y. Shoenfeld, F. Spertini, A. Wiik, R.-L. Humbel: Comparative evaluation of two anti-nuclear autoantibody (ANA) detecting assay systems, COBAS® core HEp2 ANA EIA versus IFA, by an international consensus study 

  • A. Chen, L. Bui, S. Moghaddam, J. Daedelow, K. W. Steffen, D. Thear, N. Nayak, K. J. Kontis, U. Schlensog, J. Weston, T. M. Li: Performance of the HY·TECTM 288 Plus, a fully automated EIA system for the detection of 29 clinically relevant autoantibodies

  • A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, M. Tonello, T. Del Ross, P. F. Gambari: Clinical usefulness of antibodies to Sm-B/B' UsnRNP polypeptides in CTD patients

  • D. Crosbie, K. De Bosschere, D.Cavill, F. Hulstaert, H. Pottel, S. De Keyser, H. Boeykens, T. Gordon, L. Meheus: Improved sensitivity for detection of SS-A/Ro52, SS-A/Ro60 and SS-B/La in Sjögren's syndrome using INNO-LIATM ANA update 

  • M. Jarzabek-Chorzelska, W. Meyer, M. Blaszczyk, Z. Kolacinska-Strasz, B. Teegen, S. Jablonska: Scl-70 antibodies are highly specific and prevalent in systemic scleroderma (SSc)

  • B. Pfueller, A. Bruns, S. Kuhn, H. Droege, G.-R. Burmester, F. Hiepe: Can fibronectin-IgG-complexes pretend anti-C1q autoantibodies in patients with SLE? 

  • I. Wichmann, A. Alvarez Marquez, R. García Lozano, N. Respaldiza Salas, K. Walter Pérez, M. Montes Cano, E. Rodríguez Becerra, A. Núńez Roldán: Prevalence of anti-PL-12 antibodies in interstitial lung disease

  • S. Paranos, M. Cosic, L. Jelenkovic, M. Milovanovic, Z. Sporcic: Sicca complex and organ-specific autoantibodies  

  • C. Ploix, A. Durand, S. Veber, A. Moreira, A. Desbos, J. Bienvenu, J. Orgiazzi, J. C. Monier, N. Fabien: Detection of anti-calcium sensing receptor auto-antibodies using a radioimmunoprecipitation assay

  • K. Metsküla, R. Uibo: Low incidence of nuclear, parietal cell and thyroid microsomal antibodies among males under 40 year of age in an unselected population sample from Estonia

  • R. Tozzoli, D. Villalta, N. Bizzaro, E. Tonutti, F. Manoni, D. Bassetti, A. Piazza, M. Pradella, P. Rizzotti: Analytical variability of ELISA methods for thyroid autoantibodies detection affect the clinical performances in AITD diagnosis

  • C. Dal Pra, F. Presotto, B. Pedini, M. Volpato, R. Zanchetta, C. Betterle: 21 -hydroxylase is the major target of adrenal cortex autoantibodies (ACA) in patients with different clinical forms of autoimmune Addison's disease

  • C. Betterle, C. A. Spadaccino, F. Presotto, R. Zanchetta, B. Pedini, M. Lai, N. A. Greggio, G. F. Bottazzo: The risk for type 1 diabetes mellitus (DM) increases with the number of serological markers of pancreatic autoimmunity in adult patients with organ-specific autoimmune diseases 

  • M. Schlosser, R. Wassmuth, M. Strebelow, B. Ziegler, M. Ziegler: Karlsburg type 1 diabetes risk study in normal schoolchildren – Multiple autoantibodies and genetic risk markers predict diabetes onset

  • K. Conrad, J. Rohayem, J.-Y Zhang, M. Schmitz, J. Mehlhorn, E. M. Tan, E. P. Rieber: Early diagnosis of lung cancer by combined determination of tumor-associated autoantibodies 

[back]


Pabst Science Publishers
Eichengrund 28
D-49525 Lengerich